Forian Stock (NASDAQ:FORA)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.02

52W Range

$1.97 - $4.15

50D Avg

$2.06

200D Avg

$2.49

Market Cap

$65.75M

Avg Vol (3M)

$17.88K

Beta

1.09

Div Yield

-

FORA Company Profile


Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

36

IPO Date

Mar 03, 2021

Website

FORA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21
Information and Software$26.19M$14.95M
Product and Service, Other$274.26K$804.94K
Service$1.55M$1.12M

Fiscal year ends in Dec 23 | Currency in USD

FORA Financial Summary


Dec 23Dec 22Dec 21
Revenue$20.48M$28.01M$16.88M
Operating Income$-5.00M$-20.51M$-26.41M
Net Income$11.20M$-25.97M$-26.55M
EBITDA$-4.92M$-17.09M$-24.19M
Basic EPS$0.35$-0.88$-0.90
Diluted EPS$0.35$-0.88$-0.90

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 13, 24 | 7:27 PM
Q2 24Aug 14, 24 | 7:08 PM
Q1 24May 14, 24 | 12:00 AM

Peer Comparison


TickerCompany
NRCNational Research Corporation
DHDefinitive Healthcare Corp.
HQYHealthEquity, Inc.
HSTMHealthStream, Inc.
HCATHealth Catalyst, Inc.